Trimetazidine [orch, phsu]
reduction [npop]
Mortality [qnco]
Hospitalization [hlca]
Patients [podg]
Ischaemic cardiomyopathy [dsyn]
Dilated [ftcn]
Post [tmco]
Analysis [lbpr]
Villa [euka]
Trimetazidine [orch, phsu]
Trial [resa]
Goal [inpr]
Study [mnob]
To [qlco]
effects [qlco]
Trimetazidine [orch, phsu]
Mortality [qnco]
Heart failure [dsyn]
Hospitalizations [hlca]
Patients [podg]
Ischaemic cardiomyopathy [dsyn]
Performed [ftcn]
Extension [ftcn]
months [tmco]
Post [tmco]
Analysis [lbpr]
Villa [euka]
Trimetazidine [orch, phsu]
Trial [resa]
Single [popg]
Center [spco]
OPEN LABEL [resa]
randomized [resa]
Trial [resa]
Metabolic [ftcn]
Inhibitor [qlco]
Trimetazidine [orch, phsu]
Chronic heart failure [dsyn]
Patients [podg]
randomized [resa]
Receive [qlco]
Trimetazidine [orch, phsu]
mg% [qnco]
TID [tmco]
Conventional Treatment [topp]
To [qlco]
Continue [idcn]
Usual [qlco]
Drug Therapy [topp]
Patients [podg]
Evaluated [ftcn]
baseline [bodm]
months [tmco]
Clinical examination [hlca]
Echocardiography [diap]
minute [tmco]
Walking [dora]
Test [lbpr]
Trimetazidine [orch, phsu]
Added [ftcn]
Usual [qlco]
treatment [ftcn]
Mortality [qnco]
Hazard Ratio [qnco]
Log [inpr]
Rank [inpr]
Test [lbpr]
P NOS [aapp, imft]
Heart failure [dsyn]
Hospitalization [hlca]
Log [inpr]
Rank [inpr]
Test [lbpr]
P NOS [aapp, imft]
Patient status [fndg]
Functional [ftcn]
NYHA Class [fndg]
Walking [dora]
Test [lbpr]
Trimetazidine [orch, phsu]
treated [topp]
Patients [podg]
Increase [ftcn]
Left ventricular ejection fraction [clna]
Detected [fndg]
LVEF [clna]
P NOS [aapp, imft]
months [tmco]
conclude [bodm, orch]
Long-term [tmco]
Trimetazidine [orch, phsu]
Mortality [qnco]
Heart failure [dsyn]
Hospitalization [hlca]
Patients [podg]
Ischaemic cardiomyopathy [dsyn]
confirmed [qlco]
Large [qnco]
Scale [medd]
randomized [resa]
Trial [resa]
treatment [ftcn]
Management [ocac]
Ventricular Dysfunction, Left [patf]
Patients [podg]
ischaemic heart disease [dsyn]
